Collectively, the structural truncation of Milk fat globule-EGF factor 8 (MFG-E8) enhanced its therapeutic efficacy against liver fibrosis with benefits of rapid/effective suppression of TGF-β signaling associated with integrin binding for deactivating HSCs and high productivity without concerns in clinical applications. This evidence concerns the gene TGFB1 and Hepatic fibrosis.